科普專欄–薯不揀單 - 深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)

上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1416Please respect copyright.ＰＥＮＡＮＡGWtKMMkRR3
1416Please respect copyright.ＰＥＮＡＮＡFNH0aUv7JR
上集：https://www.penana.com/article/4711251416Please respect copyright.ＰＥＮＡＮＡO7aJctPzEf
1416Please respect copyright.ＰＥＮＡＮＡ5t5YPKdiRa
1416Please respect copyright.ＰＥＮＡＮＡiAfLwGoaeD
1416Please respect copyright.ＰＥＮＡＮＡnQi51bNX4R
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1416Please respect copyright.ＰＥＮＡＮＡ8yzLzzK5Sx
1416Please respect copyright.ＰＥＮＡＮＡFbya60W0EA
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1416Please respect copyright.ＰＥＮＡＮＡ70WTFWI5kg
1416Please respect copyright.ＰＥＮＡＮＡZ5ycgiXBqw
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1416Please respect copyright.ＰＥＮＡＮＡCDXCI8grCL
1416Please respect copyright.ＰＥＮＡＮＡZ4IIaYNUOR
1416Please respect copyright.ＰＥＮＡＮＡMnBsLaEE3X
1416Please respect copyright.ＰＥＮＡＮＡ2bU3TCRsCM
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1416Please respect copyright.ＰＥＮＡＮＡ7nZ342XzMg
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1416Please respect copyright.ＰＥＮＡＮＡFBmoWuyfLO
1416Please respect copyright.ＰＥＮＡＮＡ7ZHpb3W4cj
忘記甚麼是Neoantigen的話，可重溫上一集。1416Please respect copyright.ＰＥＮＡＮＡUzLbtxkSWi
1416Please respect copyright.ＰＥＮＡＮＡUQV9O8tOKM
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1416Please respect copyright.ＰＥＮＡＮＡcOq8BwNddc
1416Please respect copyright.ＰＥＮＡＮＡLBPLsNoBfr
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1416Please respect copyright.ＰＥＮＡＮＡ66kFIWi3XC
1416Please respect copyright.ＰＥＮＡＮＡeHaimIGuzY
1416Please respect copyright.ＰＥＮＡＮＡt1A593nxRr
1416Please respect copyright.ＰＥＮＡＮＡwGHV8YoxJu
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1416Please respect copyright.ＰＥＮＡＮＡQ1BP90oQvj
1416Please respect copyright.ＰＥＮＡＮＡnXiHTUcynh
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1416Please respect copyright.ＰＥＮＡＮＡkhF1M0AnTf
1416Please respect copyright.ＰＥＮＡＮＡY0tQAZgASC
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1416Please respect copyright.ＰＥＮＡＮＡ2qeyUasVV7
1416Please respect copyright.ＰＥＮＡＮＡXyQeivboRr
1416Please respect copyright.ＰＥＮＡＮＡHdyRZxOEWp
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1416Please respect copyright.ＰＥＮＡＮＡ9IYhhSE8X2
1416Please respect copyright.ＰＥＮＡＮＡqzLRWhwsPx
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1416Please respect copyright.ＰＥＮＡＮＡw2Xt2zyFph
1416Please respect copyright.ＰＥＮＡＮＡAkcsalnNE8
1416Please respect copyright.ＰＥＮＡＮＡAXYwI7hP3w
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1416Please respect copyright.ＰＥＮＡＮＡpxMZ8qKNBT
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1416Please respect copyright.ＰＥＮＡＮＡa6xXulsEjB
1416Please respect copyright.ＰＥＮＡＮＡs9jKCnADIy
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1416Please respect copyright.ＰＥＮＡＮＡk44G9yfe6V
1416Please respect copyright.ＰＥＮＡＮＡxd650i2zmA
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1416Please respect copyright.ＰＥＮＡＮＡvp6h6nN55r
1416Please respect copyright.ＰＥＮＡＮＡscDnc7jYas
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1416Please respect copyright.ＰＥＮＡＮＡWhEYazvIxV
1416Please respect copyright.ＰＥＮＡＮＡhLaqy7bg4o
1416Please respect copyright.ＰＥＮＡＮＡSFPNAJFxw6
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1416Please respect copyright.ＰＥＮＡＮＡmEPl1hRiad
1416Please respect copyright.ＰＥＮＡＮＡiJvx4aDO5u
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1416Please respect copyright.ＰＥＮＡＮＡcqm95bnpbA
1416Please respect copyright.ＰＥＮＡＮＡnp9creh9TK
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1416Please respect copyright.ＰＥＮＡＮＡH57oB8nv7W
1416Please respect copyright.ＰＥＮＡＮＡyGHK9gLQIt
Link:1416Please respect copyright.ＰＥＮＡＮＡJdTObvNpf0
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1416Please respect copyright.ＰＥＮＡＮＡaSPaxlv0uG
1416Please respect copyright.ＰＥＮＡＮＡM6ZC5Wt7kS
1416Please respect copyright.ＰＥＮＡＮＡC7U4gjIyfM
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1416Please respect copyright.ＰＥＮＡＮＡbltjAc1jhP